Strata Skin Sciences, Inc.
SSKN
$2.59
-$0.03-1.15%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.09M | -9.38M | -8.31M | -11.36M | -10.83M |
| Total Depreciation and Amortization | 5.31M | 5.36M | 5.58M | 5.74M | 5.90M |
| Total Amortization of Deferred Charges | 148.00K | 137.00K | 127.00K | 130.00K | 140.00K |
| Total Other Non-Cash Items | 4.13M | 3.01M | 3.33M | 4.46M | 4.34M |
| Change in Net Operating Assets | 688.00K | 1.73M | -1.59M | 525.00K | -69.00K |
| Cash from Operations | 188.00K | 856.00K | -862.00K | -506.00K | -519.00K |
| Capital Expenditure | -1.64M | -2.85M | -2.59M | -3.95M | -5.02M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.64M | -2.85M | -2.59M | -3.95M | -5.02M |
| Total Debt Issued | -- | 0.00 | 0.00 | 7.00M | 7.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.94M | 1.94M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -18.00K | -18.00K | -122.00K | -157.00K | -139.00K |
| Cash from Financing | 1.93M | 1.93M | -122.00K | 6.84M | 6.86M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 477.00K | -69.00K | -3.58M | 2.39M | 1.32M |